Literature DB >> 18507352

[Preliminary study on sea cucumber saponin-nobiliside A liposome and its hemolytic activity].

Yang Xiong1, Dan Guo, Xiao-Li Zheng, Peng Sun, Lian-Ying Xu, Jian-Ming Chen.   

Abstract

Nobiliside A (Nob A) liposomes were prepared. Its assay method of content and encapsulation efficiency (EE) were established, and hemolytic activity with Nob A solution in vivo and in vitro were compared. Preparative method, phospholipid content, ratio of phospholipid to cholesterol and ratio of drug to lipids were optimized by single factor exploration. According to the optimized results, 3 batches of Nob A liposomes were prepared, then high performance liquid chromatography coupled with evaporative light scattering detector (HPLC-ELSD) method was used to determine the content of Nob A and minicolumn centrifugation method to determine EE, transmission electron microscope was used to detect the morphology and laser scatter analysis to evaluate particle sizes of the liposomes. The hemolytic activity was studied both in vivo and in vitro. The results indicated that HPLC-ELSD method and minicolumn centrifugation method used in this study are simple, applicable and accurate for the determination of the content and EE of Nob A liposome respectively . Nob A liposomes have a high EE with spherical shape and uniform size by using the film ultrasonication technique. When the ratio of phospholipid to cholesterol was 2:1 and the ratio of Nob A to lipids was 1:40, the mean EE of Nob A liposomes was 95.7% and the mean diameter was 87.6 nm. Liposomes inhibited the hemolytic activity of Nob A in vivo and in vitro sharply. As for its low hemolytic activity in vivo and in vitro, Nob A liposomes are optimistic to be used by intravenous injection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18507352

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  2 in total

1.  Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant.

Authors:  Ji-Hui Zhao; Qi-Bo Zhang; Bao Liu; Xiang-Hua Piao; Yu-Lu Yan; Xiao-Ge Hu; Kuan Zhou; Yong-Tai Zhang; Nian-Ping Feng
Journal:  Int J Nanomedicine       Date:  2017-07-04

2.  Formulations, hemolytic and pharmacokinetic studies on saikosaponin a and saikosaponin d compound liposomes.

Authors:  Guo-Song Zhang; Peng-Yi Hu; Dong-Xun Li; Ming-Zhen He; Xiao-Yong Rao; Xiao-Jian Luo; Yue-Sheng Wang; Yu-Rong Wang
Journal:  Molecules       Date:  2015-04-03       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.